Patrick Campbell

An analysis of data from 130 women suggests those with hypertensive disorders of pregnancy were at an increased risk of cardiovascular disease later in life, even if they had no baseline history of cardiovascular disease.

A review of 39 randomized clinical trials examining weight loss interventions is providing clinicians with an overview of engagement rates, mediums used, and effects of digital self-monitoring for weight loss among obese or overweight patients.

Using data from the Women's Health Initiative, a new analysis found increased intake of plant protein was linked to lower risk of all-cause mortality, as well as deaths related to cardiovascular disease and dementia, in postmenopausal women.

An observational analysis of data from more than 120k patients provides an overview of cerebral embolic protection devices and risk of in-hospital stroke among patients undergoing TAVR.

An analysis of more than 2k patients from within the Look AHEAD study suggests the timing of physical activity could play a role in mitigating cardiovascular risk among men with type 2 diabetes considered overweight or obese.

An analysis of data from more than 130 women suggests hypertensive disorders of pregnancy were associated with cardiac remodeling and risk of cardiovascular disease later in life.

Analysis of data from a 12-week study by investigators in Australia suggests testosterone therapy was not associated with improvements in arterial health or function.

An analysis of more than 100 patients hospitalized with severe COVID-19 indicates subsequent heart damage was discovered in more than half of these patients in imaging more than a month after discharge.

An analysis of more than 2k mother-child dyads suggests assessments of cardiovascular health could provide insight into the health of offspring during adolescence.

An analysis of data from the APPROACH registry suggest early revascularization with CABG or PCI may be a more effective approach than medical therapy in patients with stable ischemic heart disease and high-risk cardiac anatomy.

Data from a 20-year follow-up of gender diverse individuals indicate transgender men receiving testosterone therapy were at an 11% increased risk of developing erythrocytosis.

An analysis of more than 2k mother-child pairs indicates assessments of maternal cardiovascular health could shed light on the potential for poor cardiovascular health among their children at ages 10-14 years.

An analysis of nearly 150 patients with severe COVID-19 and increased troponin levels indicates more than half of those patients went on to develop infarction, myocarditis, ischemia, or a combination of the three.

This episode of the Endocrine Outlook podcast features an interview on dietary interventions and the role of nutrition in obesity management with Ariana Chao, PhD, CRNP, of the University of Pennsylvania.

Novartis announced the US FDA has expanded the label for sacubitril/valsartan (Entresto) to include reducing the risk of CV death and hospitalizations for heart failure among patients with chronic heart failure.

An intervention trial from Germany suggests specialized mobile stroke units could help improve rates of disability and death following a stroke.

An analysis of more than 28k incident myocardial infarction events demonstrates increased physical activity levels were associated with a 21-45% lower risk of instant death and a 15-36% lower risk of death in the first 28 days.

An analysis of data from the UK Biobank cohort is adding to the understanding of HbA1c and neurological health, suggesting patients with prediabetes were at an increased risk of cognitive decline and vascular dementia.

A recent study from Northwestern University suggests 30-53% of all new diabetes cases in the United States were directly attributable to obesity.

An analysis of data from the TRUST trial supports guideline recommendations against levothyroxine for reducing depressive symptoms in older adults with subclinical hypothyroidism.

An analysis of data from 195 countries over a nearly 3 decade period indicates prevalence and burden of heart failure have continued to grow since 1990.

A statement from Regeneron announced their ANGPTL3 inhibitor evinacumab (Evkeeza) received approval as an adjunct therapy for lowering LDL-C in patients 12 years and older with homozygous familial hypercholesterolemia.

An analysis of data from an ethnically diverse cohort of more than 120k patients indicates Chinese adults were more susceptible to obesity-related health complications, such as hypertension, than other racial/ethnic groups.

An analysis of data from the International Consortium of Blood Pressure-Genome Wide Association Studies suggests every 1 mmHg increase in blood pressure was linked to a 1.4-2.6% increase in risk of atrial fibrillation.

An analysis of more than 200 children indicates type 1 diabetes was linked to persistent differences in total IQ and white matter volume among children with type 1 diabetes.

A new report published in the Journal of the American Heart Association suggests obesity was linked to 30-53% of all new cases of diabetes within the United States.

Data from an analysis of nearly 400k older patients suggests Medicare Advantage beneficiaries were less likely than their counterparts with commercial insurance to be prescribed newer glucose-lowering agents such as GLP-1RAs and SGLT2 inhibitors.

An analysis of data from a trio of major cardiovascular studies details the apparent decrease in risk of incident heart failure associated with increased intake of coffee.

A trial from LSU's Pennington Biomedical Research Lab indicates a health coach-led intervention in primary care settings was associated with improvements in fasting blood glucose and HDL-C cholesterol.

An intervention implementing the use of a health coach in a primary care setting based on the 2013 AHA/ACC/Task Force for the Management of Overweight and Obesity in Adults guidelines was associated with greater weight loss and improvements in blood glucose levels and HDL-C compared to usual care.